Anterior vs Xsolis (2026)
Both apply AI to the decision about whether care is necessary, and they stand in different places while doing it. Anterior builds for health plans, with every recommendation reviewed and approved by human clinicians before it becomes a determination. Xsolis is the only vendor in this index positioned between payer and provider, continuously scoring medical necessity so that both sides argue from the same number, and it is the only one in this cluster with peer reviewed research behind its score, plus HITRUST risk based certification. That shared score is the more interesting proposition, because the dispute in utilization management is usually about the evidence rather than the rules. Neither publishes a bias evaluation, which is the most consequential omission in this part of the index, since the output here can end in care being denied.
- It sits between payer and provider rather than serving one side, which is a genuinely different position in utilization management and changes what both parties can argue about.
- The only vendor in the utilization management cluster with peer reviewed research, published across multiple United States health systems, and its proprietary score is unusually well evidenced for a proprietary score.
- HITRUST risk based certification at the two year tier is the strongest security position in this comparison and among the stronger ones in the index.
- It is built for health plans specifically, applying clinical AI to the review decision itself rather than to the medical necessity score underneath it.
- All recommendations are reviewed and approved by human clinicians, which is the structural safeguard that matters most when the output is a coverage decision.
- For a plan whose bottleneck is nurse and physician review capacity, a product aimed at that queue is more directly useful than a shared score.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Anterior and Xsolis are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Anterior | Xsolis |
|---|---|---|
| Primary category | RCM & Prior Auth AI | RCM & Prior Auth AI |
| Founded | 2022 | Not recorded |
| Headquarters | New York, New York, United States | Franklin, Tennessee |
| Website | anterior.com | xsolis.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Anterior its top capability grade on AI Centrality. Set against Xsolis, Anterior does not grade higher on any scored axis, though the two are level on several axes, including AI Centrality, FDA and Regulatory Status and AI Governance and Bias Disclosure. Its thinnest published disclosure sits on Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Xsolis its top capability grade on several axes, including AI Centrality, Autonomy and Oversight Model and Clinical and Operational Evidence. Set against Anterior, Xsolis grades higher on several axes, including Autonomy and Oversight Model, Model and Technology Transparency and Model Supply Chain Disclosure. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Anterior or Xsolis?
The AI Health Index grades Xsolis higher than Anterior on every axis that separates them, several axes, including Autonomy and Oversight Model, Model and Technology Transparency and Model Supply Chain Disclosure. Anterior does not grade higher on any scored axis.
Where do Anterior and Xsolis differ most?
The widest separation the AI Health Index records between Anterior and Xsolis is on Clinical and Operational Evidence, where Anterior grades C and Xsolis grades A. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do Anterior and Xsolis grade the same?
The AI Health Index grades Anterior and Xsolis the same on several axes, including AI Centrality, FDA and Regulatory Status and AI Governance and Bias Disclosure. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Anterior and Xsolis not disclosed?
At the last review, at least one of Anterior and Xsolis published thin or absent detail on Model Supply Chain Disclosure. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the RCM & Prior Auth AI page.
Utilization management is the part of this index where an AI output can result in care being denied, so the governance gap matters more here than anywhere else, and neither vendor publishes a bias evaluation or subgroup performance analysis.
Washington's rule on prior authorization states that a carrier is not exempt from compliance because it used a third party vendor and requires the programme to meet a national accreditation standard, so vendor accreditation transfers benefit and its absence transfers burden. Anterior holds no such accreditation and publishes very little on security, hosting or integrations. Neither vendor publishes pricing, and Xsolis additionally sells a physician advisory service alongside the platform, which is a different commercial shape from software alone.